Loading organizations...
Loading organizations...
R&D of innovative drugs and generic drug technology transfer.
Weikaier Pharmaceutical Technology has raised $63.2M across 1 funding round.
Weikaier Pharmaceutical Technology has raised $63.2M in total across 1 funding round.
Weikaier Pharmaceutical Technology has raised $63.2M in total across 1 funding round.
Weikaier Pharmaceutical Technology's investors include Dyee Capital.
Weikaier Pharmaceutical Technology has raised $63.2M across 1 funding round. Most recently, it raised $63.2M Series C in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 2, 2024 | $63.2M Series C | Dyee Capital |